Cambridge, UK, 17 September 2018: Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced it...

Ajdovšcina, Slovenia, 17 September 2018: BIA Separations, a leading biochromatography development and manufacturing company, today announced the expansion of its ser...

(Vienna, 14 September 2018) An international research team led by Wolfgang Weninger, who has been Head of MedUni Vienna's Department of Dermatology since 1 September,...

Cambridge, UK, 14 September 2018: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologie...

This year at the Eastern Economic Forum in Vladivostok, BIOCAD and Shanghai Pharmaceuticals Holding entered into a Memorandum of Understanding to create two joint v...

- Novo REPAIR Impact Fund to invest up to CHF 11.5M in Polyphor's antibiotic OMPTA pipeline through a CHF 6.8M equity investment, as well as a potential additional CH...

CAMBRIDGE, UK and ALBANY, NY, 05 September 2018: Metrion Biosciences Limited (“Metrion”), the specialist ion channel CRO and drug discovery company, and AMRI, a globa...

Investment in the German CRO, specialized in the preclinical assessment of new anticancer drugs, strengthens Citoxlab’s pharmacology portfolio, which will benefit fro...

(Vienna, 31 August 2018) Anaplastic large-cell lymphomas (ALCL) are rare cancers of the white blood cells. New research from the international ERIA consortium, led by...

Scientists have tested a non-addictive painkiller in primates and found it to be safe and effective. The fact that the compound was successful in a species so closely...